Scientific Articles
Effectiveness of Fulvestrant in Advanced or Metastatic Breast Cancer Patients in the Real World: A Retrospective Multi-center Cohort Study with 1072 Patients (JBCRG-C06; Safari)
Hidetoshi Kawaguchi, Norikazu Masuda, Takahiro Nakayama, Kenjiro Aogi, Keisei Anan, Yoshinori Ito, Shoichiro Ohtani, Nobuaki Sato, Shigehira Saji, Eriko Tokunaga, Seigo Nakamura, Yoshie Hasegawa, Masaya Hattori, Tomomi Fujisawa, Satoshi Morita, Miki Yamaguchi, Yutaka Yamamoto, Shinji Ohno and Masakazu Toi
Breast Cancer Research and Treatment. 2017 Jun; 163(3): 545-554. Epub 2017 Mar 23.
https://doi.org/10.1007/s10549-017-4212-x
Outcomes of trastuzumab therapy in HER2‑positive early breast cancer patients (JBCRG-C01)
Hiroyasu Yamshiro · Hiroji Iwata · Norikazu Masuda · Naohito Yamamoto · Reiki Nishimura · Shoichiro Ohtani · Nobuaki Sato · Masato Takahashi · Takako Kamio · Kosuke Yamazaki · Tsuyoshi Saito · Makoto Kato · Tecchuu Lee · Shinji Ohno · Katsumasa Kuroi · Toshimi Takano · Masahiro Takada · Shinji Yasuno · Satoshi Morita · Masakazu Toi
International Journal of Clinical Oncology. 2015 Aug; 20(4): 709-722.
https://doi.org/10.1007/s10147-015-0785-8
A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer
Norikazu Masuda, Kenji Higaki, Toshimi Takano, Nobuki Matsunami, Takashi Morimoto, Shoichiro Ohtani, Makiko Mizutani, Takeshi Miyamoto, Katsumasa Kuroi, Shinji Ohno, Satoshi Morita, Masakazu Toi
Cancer Chemotherapy and Pharmacology. 2014 Aug; 74(2): 229-38.
https://doi.org/10.1007/s00280-014-2492-y
Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study)
Masahiro Takada, Hiroshi Ishiguro, Shigenori Nagai, Shoichiro Ohtani, Hidetaka Kawabata, Yasuhiro Yanagita, Yasuo Hozumi, Chikako Shimizu, Shintaro Takao, Nobuaki Sato, Yoshimasa Kosaka, Yasuaki Sagara, Hiroji Iwata, Shinji Ohno, Katumasa Kuroi, Norikazu Masuda, Hiroyasu Yamashiro, Masahiro Sugimoto, Masahide Kondo, Yoichi Naito, Hironobu Sasano, Takashi Inamoto, Satoshi Morita & Masakazu Toi on behalf of the JBCRG-C03 Collaborative Group
Breast Cancer Research and Treatment. 2014 May; 145(1): 143-53.
https://doi.org/10.1007/s10549-014-2907-9
Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 Ring Study
Yoshiki Mikami, Takayuki Ueno, Kenichi Yoshimura, Hitoshi Tsuda, Masafumi Kurosumi, Shinobu Masuda, Rie Horii, Masakazu Toi and Hironobu Sasano
Cancer Science. 2013 Nov; 104(11): 1539–1543.
https://doi.org/10.1111/cas.12245
An Overview of the Japan Breast Cancer Research Group (JBCRG) activities
Shinji Ohno, Katsumasa Kuroi and Masakazu Toi
Breast Cancer. 2013 Oct; 20(4): 291-5.
https://doi.org/10.1007/s12282-012-0420-8
Correlation between docetaxel-induced skin toxicity and the use of steroids and H2 blockers: A multi-institution survey.
Kosuke Kawaguchi, Hiroshi Ishiguro, Satoshi Morita, Seigo Nakamura, Shinji Ohno, Norikazu Masuda, Hiroji Iwata, Kenjiro Aogi, Katsumasa Kuroi, Masakazu Toi; Japan Breast Cancer Research Group (JBCRG)
Breast Cancer Research and Treatment. 2011; 130(2): 627-634.
https://doi.org/10.1007/s10549-011-1641-9
Economic evaluation of the 21-gene signature (Oncotype DX(®)) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRG-TR03).
Masahide Kondo, Shu-Ling Hoshi, Takeharu,Yamanaka, Hiroshi Ishiguro, Masakazu Toi
Breast Cancer Research and Treatment. 2011 Jun; 127(3): 739-49.
https://doi.org/10.1007/s10549-010-1243-y
Clinical Significance of the 21-Gene Signature (Oncotype DX) in Hormone Receptor-Positive Early Stage Primary Breast Cancer in the Japanese Population
Masakazu Toi, Hiroji Iwata, Takeharu Yamanaka, Norikazu Masuda, Shinji Ohno, Seigo Nakamura, Takahiro Nakayama, Masahiro Kashiwaba, Shunji Kamigaki, Katsumasa Kuroi; and the Japan Breast Cancer Research Group-Translational Research
Cancer.2010 Jul; 116(13): 3112-3118
https://doi.org/10.1002/cncr.25206
by Voluntary Organization JBCRG